- Issue price
- ₹45per share
- Issue size
- ₹138.87 Cr3,08,59,704 shares
- Face value
- ₹1per equity share
- Lot size
- 333 sharesMin. ₹14,985 at the upper price
- Anchor biddingThu, 2026
- OpensFri, 2026
- ClosesTue, 2026
- AllotmentThu, 2026Refunds and Demat credit same day
- ListingFri, 2026
Dates marked in the offer document as tentative. Times in IST.
Information only, not investment advice. This page provides information compiled from official offer documents for information purposes only. It is not investment advice or a recommendation to apply for, buy or sell any security. We are not a SEBI-registered investment adviser or research analyst. Investments in IPOs are subject to market risks; read the offer document carefully before investing.
Issue details
- Issue type
- Book built, fresh issue and offer for sale
- Fresh issue
- —
- Offer for sale
- 3,08,59,704 shares (₹138.87 Cr)
- Total issue
- 3,08,59,704 shares (₹138.87 Cr)
- Face value
- ₹1
- Listing at
- NSE, BSE
- Promoter holding
- 28.81% → 24.63%
Source: ProspectusUpdated
Reservation
Share of the total issue- Retail35.0%
- Anchor30.0%
- QIB ex-anchor20.0%
- Small NII10.0%
- Big NII5.0%
| Category | Shares | Of net offer | Stated in RHP |
|---|---|---|---|
| Retail individual investors | 1,08,00,897 | 35.00% | 35% |
| Non-institutional investors (NII) | 46,28,956 | 15.00% | 15% |
| Small NII (₹2–10 lakh) | 30,85,971 | 10.00% | — |
| Big NII (above ₹10 lakh) | 15,42,985 | 5.00% | — |
| Qualified institutional buyers (QIB) | 1,54,29,851 | 50.00% | 50% |
| QIB, excluding anchor | 61,72,155 | 20.00% | — |
| Anchor investors | 92,57,696 | 30.00% | — |
Source: ProspectusUpdated
Lot size
Amounts at ₹45 per share| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail individual investors | 1 | 333 | ₹14,985 |
Source: ProspectusUpdated
Subscription
Category-wise subscription is published by the exchanges while the issue is open. It appears here once the figures are added.
Valuation
FY 2024-25, pre-issue- EPS (basic)
- ₹1.75
- EPS (diluted) (Nine month period ended December 31, 2025)
- ₹2.2
- P/E (FY 2024-25 diluted EPS at cap price)
- 25.71×
- RoNW
- 12.46%
- NAV per share (As at December 31, 2025)
- ₹18.15
- Debt to equity (As at December 31, 2025)
- 0.18
Source: ProspectusUpdated
Financials
Consolidated, restated · ₹ crore| Period ended | 31 Dec 20259 months | 31 Mar 2025FY 2024-25 | 31 Mar 2024FY 2023-24 | 31 Mar 2023FY 2022-23 |
|---|---|---|---|---|
| Revenue from operations | 267.59 | 324.93 | 297.73 | 278.50 |
| Total income | 275.57 | 331.29 | 304.62 | 281.65 |
| EBITDA | 37.55 | 40.07 | 24.88 | 17.17 |
| Profit after tax | 27.03 | 24.38 | 12.21 | 5.82 |
| Net worth | 220.94 | 194.18 | 175.87 | 163.08 |
| Reserves and surplus | 209.88 | 183.12 | 164.81 | 152.02 |
| Total assets | 327.60 | 261.36 | 250.54 | 288.90 |
| Total borrowing | 39.79 | — | — | — |
FY 2024-25 vs FY 2023-24: revenue +9.1%, profit after tax +99.6%. Periods shorter than 12 months are shown as reported and are not annualised.
Source: ProspectusUpdated
About the company
The company makes micronutrient premixes for food fortification and supplies them to FMCG and multinational clients. It also sells branded wellness and clinical nutrition products and ready-to-use therapeutic foods and micronutrient powders for public health programmes. It operates manufacturing facilities in India and one in Uzbekistan and exports to many countries.
- Incorporated
- 1993
- Industry
- Nutrition and Nutraceuticals
- CIN
- U24110MH1993PLC072189
- Website
- hexagonnutrition.com
Source: ProspectusUpdated
Promoters and shareholders
| Name | Type | Before issue | After issue | Shares offered |
|---|---|---|---|---|
| Arun Purushottam Kelkar | Promoter | — | — | 15,36,477 |
| Subhash Purushottam Kelkar | Promoter | — | — | 2,41,88,993 |
| Nikhil Arun Kelkar | Promoter | 17.26% | 17.26% | — |
| Aditya Kelkar | Promoter | 1.24% | 0.00% | 15,26,092 |
| Anuradha Arun Kelkar | Promoter group | 7.37% | 7.37% | — |
| Nutan Subhash Kelkar | Promoter group | 2.94% | 0.00% | 36,08,142 |
Source: ProspectusUpdated
Objects of the issue
₹ crore| Purpose | Amount |
|---|---|
| Offer for sale of equity shares by the selling shareholders; the company receives no proceeds | 138.87 |
| Estimated offer-related expenses, borne by the selling shareholders | 16.39 |
Source: ProspectusUpdated
Peer comparison
As listed in the offer document| Company | EPS | P/E | RoNW | NAV per share |
|---|---|---|---|---|
| Hexagon Nutrition LimitedIssuer | ₹1.75 | 25.71× | 12.46% | ₹15.91 |
| Zydus Wellness Limited | ₹10.9 | 46.22× | 6.12% | ₹178.26 |
| Nestlé India Limited | ₹16.63 | 88.86× | 77.91% | ₹21.35 |
Source: ProspectusUpdated
Strengths and risks
Our summary of what the offer document statesStrengths
- Two decades of experience in micronutrient premix manufacturing, with exports to many countries.
- Established branded wellness and clinical nutrition portfolio.
- Long-standing relationships with institutional and FMCG clients that generate repeat orders.
- Multiple manufacturing sites with food safety certifications.
- Revenue and profit growth over the period reviewed.
Risks
- Heavy dependence on the premix formulation segment for a large share of revenue.
- Reliance on a limited number of customers for significant revenue.
- Exposure to volatile imported raw material prices and currency movements.
- Export and supply chain disruptions from geopolitical events.
- Production disruption risk at key facilities, including a planned structural alteration at the Nashik facility.
Source: ProspectusUpdated
Documents
Contacts
Source: ProspectusUpdated
Allotment status
Check whether shares were allotted on the official pages below, using your PAN, application number or DP/client ID. Results appear once the basis of allotment is finalised.
- Allotment
- Refunds
- Demat credit
- Listing
Source: ProspectusUpdated
After listing
Listing price, day-one high and low, and the change from the issue price (₹45) appear here after the shares list on NSE and BSE.
Work out the gain or loss on allotted shares after charges and tax →
Frequently asked questions
When does the Hexagon Nutrition IPO open and close?
According to the Prospectus, the issue opens on Friday, 5 June 2026 and closes on Tuesday, 9 June 2026.
What is the Hexagon Nutrition IPO price band?
The final issue price is ₹45 per share.
What is the lot size of the Hexagon Nutrition IPO?
One lot is 333 shares, which is ₹14,985 at ₹45 per share.
Where will Hexagon Nutrition shares list?
On NSE and BSE. The tentative listing date is Friday, 12 June 2026.
Who is the registrar of the issue?
KFin Technologies Limited (SEBI registration INR000000221). Allotment status is checked on the registrar's website.
How do I check the Hexagon Nutrition IPO allotment status?
The basis of allotment is expected to be finalised on Thursday, 11 June 2026. After that, search by PAN, application number or DP/client ID on the registrar's website (KFin Technologies Limited), the NSE website or the BSE website. Shares that are allotted are credited to your demat account; for an application that is not allotted, the blocked amount is released.
How will the money raised be used?
₹138.87 Cr for offer for sale of equity shares by the selling shareholders; the company receives no proceeds, ₹16.39 Cr for estimated offer-related expenses, borne by the selling shareholders.
Related IPOs
Spotted something wrong?
Our data comes from official offer documents, but mistakes can slip through. Report an error and tell us which figure looks wrong and where you saw the correct one (the offer-document page number helps). For anything else, see Contact.